Type
Full Body Checkup
Duration
5 hours
An expanded health screening programme for women over 40, building on the standard check-up with age-appropriate additions including mammography, bone densitometry, and extended endocrinology consultation. Designed to address the screening priorities that become increasingly relevant during and after the perimenopausal transition.
The years around and after 40 bring significant physiological changes for women. Oestrogen levels begin to fluctuate and eventually decline, influencing cardiovascular risk, bone density, body composition, and metabolic function. This programme adds screening components that target those evolving risk areas while retaining the comprehensive blood work and imaging of the base check-up. Mammography replaces breast ultrasound as the primary breast imaging modality, reflecting clinical guidelines that recommend mammographic screening from age 40 or 50 depending on jurisdiction and personal risk factors. In this programme both may be used depending on clinical judgement and breast tissue density. Bone densitometry (DEXA) is added to screen for osteopenia and osteoporosis — conditions that may begin developing silently well before menopause, particularly in women with risk factors such as low body weight, family history, or long-term corticosteroid use. The endocrinology consultation provides specialist review of thyroid, metabolic, and hormonal markers. Thyroid disorders become more prevalent with age and may present with symptoms — fatigue, weight gain, mood changes, hair thinning — that overlap significantly with perimenopausal complaints, making differentiation clinically important. The expanded cardiovascular assessment reflects the rising cardiac risk that accompanies declining oestrogen. This package is suited for women who want their screening to account for the specific health transitions of this life stage.
Key Details
- Duration
- ~5 hours
- Consultations
- 4 specialists
- Gender
- Female
- Age group
- Over 40
Who Is This For?
Women over 40, perimenopausal screening, breast and bone health assessment, cardiovascular risk evaluation
